Page last updated: 2024-10-26

donepezil and Corticobasal Degeneration

donepezil has been researched along with Corticobasal Degeneration in 1 studies

Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.

Corticobasal Degeneration: Rare progressive neurological disorder characterized by Parkinsonism, cortical atrophy of multiple areas of the brain including the cerebral cortex and the basal ganglia, cognitive dysfunction and eye movement abnormalities.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Prado, MB1
Adiao, KJ1

Reviews

1 review available for donepezil and Corticobasal Degeneration

ArticleYear
Corticobasal syndrome etiologies in a young Filipino patient: A case report and literature review.
    Clinical neurology and neurosurgery, 2021, Volume: 210

    Topics: Adult; Baclofen; Corticobasal Degeneration; Donepezil; Dopamine Agents; Fatal Outcome; GABA-B Recept

2021